Natural Health Farm Holdings Inc. (NHEL)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Natural Health Farm Holdings Inc. (NHEL) trades at $0.00 with AI Score 55/100 (Grade B). Natural Health Farm Holdings Inc. is a development stage biotechnology company focused on creating a healthcare ecosystem based on natural products. Market cap: $16,219, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for NHEL: NHEL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NHEL against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
NHEL: 2/6 perspectives are bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Natural Health Farm Holdings Inc. (NHEL) Healthcare & Pipeline Overview
Natural Health Farm Holdings Inc., a development-stage biotechnology company based in Malaysia, focuses on developing a healthcare ecosystem centered around natural and naturopathic products. Trading on the OTC market, the company aims to leverage natural health solutions within the healthcare sector, facing challenges typical of early-stage biotech ventures.
What Is the Investment Thesis for NHEL?
Investing in Natural Health Farm Holdings Inc. presents a high-risk, high-reward scenario typical of development-stage biotechnology companies. The company's focus on natural health products aligns with growing consumer demand for alternative healthcare solutions. However, the company's negative profit margin of -36.6% and ROE of -32.1% indicate significant financial challenges. Key value drivers include successful development and commercialization of its product pipeline, securing regulatory approvals, and expanding its market presence. The company's high beta of -93.23 suggests extreme volatility compared to the market. Investors should carefully consider the risks associated with investing in an OTC-listed, development-stage company with limited financial resources.
Based on FMP financials and quantitative analysis
NHEL Key Highlights
- Market capitalization of 16K indicates a micro-cap company with limited financial resources.
- Gross margin of 68.6% suggests potential for profitability if sales volume increases.
- Negative profit margin of -36.6% reflects ongoing losses and the need for significant revenue growth.
- Debt-to-equity ratio of 29.57 indicates moderate leverage.
- Negative ROE of -32.1% highlights the company's inefficiency in generating profits from equity.
Who Are NHEL's Competitors?
NHEL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| ACCD Accolade, Inc. | $7.02 | +0.00% | $575.59M | 55 |
| ONEM ONEM | $16.47 | +0.00% | $3.40B | 55 |
| SUSRF Surgical Science Sweden AB (publ) | $4.00 | +0.00% | $204.10M | 55 |
| SLGCW SomaLogic, Inc. | $0.09 | -28.33% | $396.23M | 55 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NHEL's Key Strengths?
- Focus on natural health products aligns with consumer trends.
- Proprietary formulations and research.
- Potential for high gross margins.
- Experienced management team.
What Are NHEL's Weaknesses?
- Development stage company with limited financial resources.
- Negative profit margin and ROE.
- OTC listing increases risk and volatility.
- Limited market presence and brand recognition.
What Could Drive NHEL Stock Higher?
- Potential regulatory approvals for key products.
- Announcement of strategic partnerships with healthcare providers.
- Launch of e-commerce platform for direct-to-consumer sales.
What Are the Key Risks for NHEL?
- Financial-distress signal — its Altman Z-Score of -0.13 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Limited financial resources and negative profitability.
- Regulatory challenges and compliance costs.
- Competition from established healthcare companies.
- Market acceptance of alternative therapies.
- OTC listing and associated risks.
What Are the Growth Opportunities for NHEL?
- Expansion of Product Line: Natural Health Farm Holdings Inc. can expand its product line to include a wider range of natural health products, such as dietary supplements, herbal remedies, and personal care items. The global dietary supplements market is projected to reach $230.73 billion by 2027, offering a significant opportunity for growth. Successful product diversification could enhance revenue streams and brand recognition.
- Strategic Partnerships: Forming strategic partnerships with established healthcare providers, retailers, and distributors can accelerate market access and product adoption. Collaborating with complementary medicine clinics and wellness centers can provide a direct channel to reach target customers. These partnerships could be established within the next 1-2 years, contingent on successful product development and regulatory approvals.
- E-commerce Platform Development: Developing a robust e-commerce platform can enable direct-to-consumer sales and expand the company's geographic reach. The global e-commerce market is experiencing rapid growth, driven by increasing internet penetration and online shopping adoption. An e-commerce platform could be launched within the next year, providing a cost-effective channel for reaching a wider customer base.
- International Expansion: Expanding into international markets, particularly in Asia and Europe, can unlock new growth opportunities. The demand for natural health products is growing globally, driven by increasing awareness of preventive healthcare and wellness. International expansion could be pursued within the next 2-3 years, contingent on securing regulatory approvals and establishing distribution networks.
- Research and Development: Investing in research and development to develop innovative natural health products can create a competitive advantage and attract new customers. Focusing on evidence-based research to validate the efficacy and safety of its products can enhance credibility and build trust with consumers. Continuous R&D is crucial for staying ahead of the competition and meeting evolving consumer needs.
What Opportunities Does NHEL Have?
- Expansion of product line and geographic reach.
- Strategic partnerships with established healthcare providers.
- Development of e-commerce platform.
- Increasing demand for natural health products.
What Threats Does NHEL Face?
- Regulatory scrutiny and compliance challenges.
- Competition from established healthcare companies.
- Market acceptance of alternative therapies.
- Economic downturn and reduced consumer spending.
What Are NHEL's Competitive Advantages?
- Focus on natural and naturopathic products.
- Proprietary formulations and research.
- Strategic partnerships within the healthcare industry.
- Brand reputation and customer loyalty.
What Does NHEL Do?
Natural Health Farm Holdings Inc., established in 2014 and headquartered in Rawang, Malaysia, is a biotechnology company in the development stage. The company is focused on creating a healthcare ecosystem based on natural and naturopathic products. Formerly known as Amber Group, Inc., the company rebranded to Natural Health Farm Holdings Inc. in March 2017, signaling a strategic shift towards natural health solutions. As a development stage company, Natural Health Farm Holdings Inc. is currently focused on research and development of its product offerings. The company's focus on natural products aligns with growing consumer interest in alternative and complementary medicine. However, as an OTC-listed company with a small market capitalization, Natural Health Farm Holdings Inc. faces challenges related to funding, regulatory approvals, and market acceptance. The company's success will depend on its ability to successfully develop and commercialize its natural health products and navigate the competitive healthcare landscape.
What Products and Services Does NHEL Offer?
- Develops healthcare eco-systems based on natural products.
- Focuses on biotechnology research and development.
- Aims to create alternative healthcare solutions.
- Markets and distributes natural health products.
- Conducts research on naturopathic remedies.
- Seeks regulatory approvals for its products.
- Forms strategic partnerships within the healthcare industry.
How Does NHEL Make Money?
- Develops and commercializes natural health products.
- Generates revenue through product sales.
- Partners with distributors and retailers.
- Invests in research and development to create new products.
What Industry Does NHEL Operate In?
Natural Health Farm Holdings Inc. operates in the healthcare information services industry, which is experiencing growth driven by increasing demand for personalized medicine and digital health solutions. The market is competitive, with established players like McKesson Corporation and Cerner Corporation, as well as emerging companies focused on niche areas such as telehealth and remote patient monitoring. Natural Health Farm Holdings Inc.'s focus on natural health products differentiates it from traditional healthcare providers, but it also faces challenges related to regulatory scrutiny and market acceptance of alternative therapies.
Who Are NHEL's Key Customers?
- Individuals seeking natural health solutions.
- Healthcare providers interested in alternative therapies.
- Retailers and distributors of health products.
- Wellness centers and complementary medicine clinics.
F-Score 2/9Financial Health
Natural Health Farm Holdings Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.13 places it in the distress zone, a signal of elevated financial risk.
Natural Health Farm Holdings Inc. (NHEL) Valuation Context
Valued at 16K, NHEL is classified as a micro-cap stock. Relative to its peer group, NHEL's quantitative score of 55/100 is below the peer average of 65/100.
Company Profile
Natural Health Farm Holdings Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Rawang, MY. The company is led by CEO Chuen Meng Tee. NHEL has traded publicly since 2018.
NHEL Financials
Bull Case vs Bear Case
Bull Case
- Focus on natural health products aligns with consumer trends.
- Proprietary formulations and research.
- Potential for high gross margins.
- Experienced management team.
Bear Case
- Development stage company with limited financial resources.
- Negative profit margin and ROE.
- OTC listing increases risk and volatility.
- Limited market presence and brand recognition.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
NHEL Latest News
No recent news available for NHEL.
NHEL Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NHEL.
Price Targets
Wall Street price target analysis for NHEL.
NHEL MoonshotScore
What does this score mean?
The MoonshotScore rates NHEL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Chuen Meng Tee
CEO
Chuen Meng Tee serves as the Chief Executive Officer of Natural Health Farm Holdings Inc. His background includes experience in business development and strategic planning within the healthcare sector. He has a proven track record of leading teams and driving growth in emerging markets. Mr. Tee holds a degree in Business Administration and has completed executive education programs focused on leadership and innovation.
Track Record: Since assuming the role of CEO, Chuen Meng Tee has focused on repositioning the company towards natural health solutions and securing strategic partnerships. He has overseen the rebranding of the company and the development of its initial product pipeline. His leadership has been instrumental in navigating the challenges of operating as a development-stage company in a competitive industry.
NHEL OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Natural Health Farm Holdings Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosures and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries significant risks due to the potential for fraud, lack of transparency, and limited liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosures and transparency.
- Potential for fraud and manipulation.
- High price volatility and illiquidity.
- Lack of regulatory oversight and investor protection.
- Going concern risk due to limited financial resources.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's management team and track record.
- Evaluate the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal proceedings.
- Company registration and legal compliance.
- Presence of a management team and board of directors.
- Focus on developing natural health products.
- Strategic partnerships within the healthcare industry.
- Efforts to secure regulatory approvals.
What Investors Ask About Natural Health Farm Holdings Inc. (NHEL) — Healthcare
What does Natural Health Farm Holdings Inc. do?
Natural Health Farm Holdings Inc. is a development-stage biotechnology company focused on creating a healthcare ecosystem based on natural and naturopathic products. The company aims to develop and commercialize a range of natural health products, including dietary supplements, herbal remedies, and personal care items. It operates primarily in Malaysia and seeks to expand its market presence through strategic partnerships and e-commerce initiatives. The company's success depends on its ability to secure regulatory approvals, develop innovative products, and build a strong brand reputation.
What do analysts say about NHEL stock?
As of March 18, 2026, there is limited analyst coverage of Natural Health Farm Holdings Inc. due to its OTC listing and small market capitalization. Key valuation metrics, such as price-to-earnings ratio and price-to-sales ratio, are not meaningful due to the company's negative profitability. Growth considerations include the company's ability to secure regulatory approvals, expand its product line, and penetrate new markets. Investors should conduct their own thorough research and consider the risks associated with investing in an OTC-listed, development-stage company.
What are the main risks for NHEL?
The main risks for Natural Health Farm Holdings Inc. include its limited financial resources, negative profitability, and OTC listing. The company faces regulatory challenges and compliance costs associated with developing and commercializing natural health products. Competition from established healthcare companies and market acceptance of alternative therapies also pose significant risks. Additionally, the company's OTC listing increases the risk of price volatility, illiquidity, and potential for fraud. Investors should carefully consider these risks before investing in NHEL.
What are the key factors to evaluate for NHEL?
Natural Health Farm Holdings Inc. (NHEL) holds an AI score of 55/100 (moderate). Not financial advice.
How frequently does NHEL data refresh on this page?
NHEL prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NHEL's recent stock price performance?
Natural Health Farm Holdings Inc. (NHEL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on natural health products aligns with consumer trends. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NHEL overvalued or undervalued right now?
Valuing Natural Health Farm Holdings Inc. (NHEL) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NHEL?
Before investing in Natural Health Farm Holdings Inc. (NHEL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company due to its OTC listing and development stage.
- Financial data may not be fully reliable due to limited disclosures.